(Q38109029)

29 August 2017

title

Progesterone signalling in breast cancer: a neglected hormone coming into the limelight (English)

1 reference

29 August 2017

1 reference

1

Cathrin Brisken

1 reference

29 August 2017

language of work or name

English

0 references

publication date

1 June 2013

1 reference

29 August 2017

published in

Nature Reviews Cancer

1 reference

29 August 2017

volume

13

1 reference

29 August 2017

issue

6

1 reference

29 August 2017

page(s)

385-396

1 reference

Comprehensive molecular portraits of human breast tumours

29 August 2017

cites work

1 reference

Sequence analysis of mutations and translocations across breast cancer subtypes

31 March 2020

1 reference

Intra-tumour heterogeneity: a looking glass for cancer?

31 March 2020

1 reference

Cellular heterogeneity and molecular evolution in cancer

31 March 2020

1 reference

Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies

31 March 2020

1 reference

Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways

31 March 2020

1 reference

Hormonal synergism in mammary growth

31 March 2020

1 reference

Risk factors for breast cancer according to estrogen and progesterone receptor status

31 March 2020

1 reference

'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer

31 March 2020

1 reference

Cyclic Variation of DNA synthesis in human breast epithelium

31 March 2020

1 reference

A correlative morphologic study of human breast and endometrium in the menstrual cycle

31 March 2020

1 reference

On the origin and progression of ductal carcinoma in the human breast

31 March 2020

1 reference

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

31 March 2020

1 reference

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

31 March 2020

1 reference

Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial

31 March 2020

1 reference

Breast cancer and hormone-replacement therapy: the Million Women Study

31 March 2020

1 reference

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women

31 March 2020

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

31 March 2020

1 reference

Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study

31 March 2020

1 reference

Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort

31 March 2020

1 reference

Pharmacological profile of progestins

31 March 2020

1 reference

Changes in invasive breast cancer and ductal carcinoma in situ rates in relation to the decline in hormone therapy use.

31 March 2020

1 reference

Breast cancer after use of estrogen plus progestin in postmenopausal women

31 March 2020

1 reference

Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis

31 March 2020

1 reference

Mammographic Density and the Risk and Detection of Breast Cancer

31 March 2020

1 reference

Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density

31 March 2020

1 reference

Postmenopausal hormone therapy and change in mammographic density

31 March 2020

1 reference

Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland.

31 March 2020

1 reference

Progesterone action in normal mouse mammary gland

31 March 2020

1 reference

Effect of oestradiol on progesterone receptors in normal mammary glands and its relationship with lactation

31 March 2020

1 reference

Differential hormonal regulation and function of progesterone receptor isoforms in normal adult mouse mammary gland

31 March 2020

1 reference

Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities

31 March 2020

1 reference

Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland

31 March 2020

1 reference

A paracrine role for the epithelial progesterone receptor in mammary gland development

31 March 2020

1 reference

Alternative 5'-untranslated first exons of the mouse Cyp19A1 (aromatase) gene

31 March 2020

1 reference

Progesterone/RANKL is a major regulatory axis in the human breast.

31 March 2020

1 reference

Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development

31 March 2020

1 reference

Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland

31 March 2020

1 reference

Proliferation of estrogen receptor-alpha-positive mammary epithelial cells is restrained by transforming growth factor-beta1 in adult mice

31 March 2020

1 reference

Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development

31 March 2020

1 reference

Amphiregulin mediates estrogen, progesterone, and EGFR signaling in the normal rat mammary gland and in hormone-dependent rat mammary cancers

31 March 2020

1 reference

The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development

31 March 2020

1 reference

Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling

31 March 2020

1 reference

CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells

31 March 2020

1 reference

Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland

31 March 2020

1 reference

Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate

31 March 2020

1 reference

The Ets transcription factor Elf5 specifies mammary alveolar cell fate

31 March 2020

1 reference

Molecular portraits of human breast tumours

31 March 2020

1 reference

Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics

31 March 2020

1 reference

Identification of molecular apocrine breast tumours by microarray analysis.

31 March 2020

1 reference

Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy

31 March 2020

1 reference

Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients

31 March 2020

1 reference

Minireview: Cyclin D1: normal and abnormal functions

31 March 2020

1 reference

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

31 March 2020

1 reference

IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development

31 March 2020

1 reference

IGF-2 is a mediator of prolactin-induced morphogenesis in the breast

31 March 2020

1 reference

Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform

31 March 2020

1 reference

Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression.

31 March 2020

1 reference

Progesterone induces adult mammary stem cell expansion

31 March 2020

1 reference

Control of mammary stem cell function by steroid hormone signalling.

31 March 2020

1 reference

Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer

31 March 2020

1 reference

Distinct stem cells contribute to mammary gland development and maintenance

31 March 2020

1 reference

Developmental stage and time dictate the fate of Wnt/β-catenin-responsive stem cells in the mammary gland

31 March 2020

1 reference

Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland.

31 March 2020

1 reference

ID4 regulates mammary gland development by suppressing p38MAPK activity

31 March 2020

1 reference

Transcriptional response of the murine mammary gland to acute progesterone exposure

31 March 2020

1 reference

Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene.

31 March 2020

1 reference

RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis

31 March 2020

1 reference

RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini

31 March 2020

1 reference

Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome

31 March 2020

1 reference

Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice

31 March 2020

1 reference

WNT signalling pathways as therapeutic targets in cancer

31 March 2020

1 reference

Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling

31 March 2020

1 reference

Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors

31 March 2020

1 reference

Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells.

31 March 2020

1 reference

Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform

31 March 2020

1 reference

Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells

31 March 2020

1 reference

Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development

31 March 2020

1 reference

A genetic model for colorectal tumorigenesis

31 March 2020

1 reference

Alterations of gene expression in the development of early hyperplastic precursors of breast cancer

31 March 2020

1 reference

RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis

31 March 2020

1 reference

Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulation.

31 March 2020

1 reference

Lactoferrin expression in the mouse reproductive tract during the natural estrous cycle: correlation with circulating estradiol and progesterone.

31 March 2020

1 reference

12 December 2020

Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer

1 reference

12 December 2020

High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer

1 reference

12 December 2020

C/EBPbeta (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development

1 reference

12 December 2020

Hormone action in the mammary gland

1 reference

12 December 2020

Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography

1 reference

12 December 2020

Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling

1 reference

12 December 2020

Endocrine control of mammarygland development and function in the C3H/ He Crgl mouse

1 reference

12 December 2020

Preview: MCE special issue on molecular mechanisms of action in progesterone signalling

1 reference

12 December 2020

Case-control study of increased mammographic breast density response to hormone replacement therapy.

1 reference

12 December 2020

Age at first birth and breast cancer risk

1 reference

12 December 2020

Extracellular matrix degradation and remodeling in development and disease

1 reference

12 December 2020

An expression study of hormone receptors in spontaneously developed, carcinogen-induced and hormone-induced mammary tumors in female Noble rats

1 reference

12 December 2020

Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes

1 reference

12 December 2020

Breast cancer and hormone-replacement therapy in the Million Women Study

1 reference

12 December 2020

Dissociation between steroid receptor expression and cell proliferation in the human breast.

1 reference

12 December 2020

Assessing reproductive status/stages in mice

1 reference

12 December 2020

Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC3518

1 reference

Dimensions Publication ID

29 August 2017

1047440295

0 references

1 reference